RHI Magnesita (RHIM) Q1 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 TU earnings summary
21 Nov, 2025Executive summary
Q1 2025 saw very difficult trading conditions, with lower sales volumes and declining project business in glass and non-ferrous metals sectors worldwide.
EBITA margins declined due to lower high-margin project volumes, weaker pricing, and higher raw material costs.
The business remains cash generative and is implementing cost-saving measures and a price increase programme to restore margins, while facing competitive pressure from low-cost imports and overcapacity, especially in India and West Asia.
Plant closure in Germany and consolidation of glass refractory production announced to address low demand.
Financial highlights
Q1 sales volumes down 2% year-on-year excluding RESCO; up 1% including RESCO.
Pricing down 6% year-on-year, with a weaker mix due to lower non-ferrous metals and glass sales.
Net debt rose to €1.6 billion as of 31 March 2025, mainly due to the €391 million Resco acquisition.
Gearing (net debt to EBITDA) expected at 2.9x at half year, returning to 2.5x by year end.
Margins in Q1 were weak due to lower volumes, lower pricing, and higher raw material costs.
Outlook and guidance
H1 2025 expected to deliver only 35%-40% of annual result, with 60%-65% of profits weighted to H2, supported by postponed project volumes.
Full-year guidance maintained to be modestly ahead of 2024 adjusted EBITDA/EBITA, but downside risk has increased due to macroeconomic volatility and global trade uncertainties.
Four key drivers for H2: price increases, industrial project volume recovery, cost reductions, and SG&A savings.
If the US dollar remains at current levels, a €15 million negative impact to adjusted EBITDA/EBITA is expected.
Latest events from RHI Magnesita
- Cost actions and M&A drove H2 recovery in 2025, supporting a cautious 2026 outlook.RHIM
Q4 20252 Mar 2026 - Stable revenue and strong cash flow; EBITA guidance reaffirmed despite weak demand.RHIM
H1 20243 Feb 2026 - Margins exceeded guidance despite weak demand; EBITA outlook trimmed amid persistent overcapacity.RHIM
Q3 2024 TU15 Jan 2026 - Solid 2024 results and margin gains despite weak demand; modest growth seen for 2025.RHIM
H2 202416 Dec 2025 - Revenue and margins fell on weak demand and pricing, but H2 recovery is expected.RHIM
H1 202516 Nov 2025 - Cost savings and RESCO integration drove margin recovery despite weak demand.RHIM
Q3 2025 TU10 Nov 2025